Advertisement

Incidence, Mortality, and Cost Trends in Non-Ventilator Hospital-Acquired Pneumonia in Medicaid Beneficiaries, 2015-2019

      Abstract

      Non-ventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1000 patient days, mortality was 7.76%, with excess cost per NVHAP case of $20,189.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Munro SC
        • Baker D
        • Giuliano KK
        • Sullivan SC
        • Haber J
        • Jones BE
        • et al.
        Nonventilator hospital-acquired pneumonia: A call to action.
        Infect Control Hosp Epidemiol. 2021; 42: 991-996
        • Giuliano KK
        • Baker D
        • Quinn B.
        The epidemiology of nonventilator hospital-acquired pneumonia in the United States.
        Am J Infect Control. 2018; 46: 322-327
        • Davis JF
        • E
        A second breadth: hospital-acquired pneumonia in Pennsylvania, nonventilated versus ventilated patients.
        Pennsylvania Patient Safety Advisory. 2018; 1: 48-59
        • Hsu JL
        • Siroka AM
        • Smith MW
        • Holodniy M
        • Meduri GU.
        One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
        Int J Infect Dis. 2011; 15: e382-e387
        • Strassle PD
        • Sickbert-Bennett EE
        • Klompas M
        • Lund JL
        • Stewart PW
        • Marx AH
        • et al.
        Incidence and risk factors of non-device-associated pneumonia in an acute-care hospital.
        Infect Control Hosp Epidemiol. 2020; 41: 73-79
        • Baker D
        • Quinn B.
        Hospital acquired pneumonia prevention initiative-2: Incidence of nonventilator hospital-acquired pneumonia in the United States.
        Am J Infect Control. 2018; 46: 2-7
      1. https://www.medicaid.gov/state-overviews/scorecard/who-enrolls-medicaid-chip/index.html. Accessed June 12, 2022.

        • Lacerna CC
        • Patey D
        • Block L
        • Naik S
        • Kevorkova Y
        • Galin J
        • et al.
        A successful program preventing nonventilator hospital-acquired pneumonia in a large hospital system.
        Infect Control Hosp Epidemiol. 2020; 41: 547-552
        • Giuliano KK
        • Penoyer D
        • Middleton A
        • Baker D.
        Oral Care as prevention for nonventilator hospital-acquired pneumonia: A four-unit cluster randomized atudy.
        Am J Nsg. 2021; 121: 24-33
      2. The Joint Commission. Quick Safety Issue 61: Preventing non-ventilator hospital-acquired pneumonia.